Du, F., Yu, L., Wu, Y., Wang, S., Yao, J., Zheng, X., . . . Chen, W. (2019). miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4. Cell Death Dis.
Chicago ZitierstilDu, Feiya, et al. "MiR-137 Alleviates Doxorubicin Resistance in Breast Cancer Through Inhibition of Epithelial-mesenchymal Transition By Targeting DUSP4." Cell Death Dis 2019.
MLA ZitierstilDu, Feiya, et al. "MiR-137 Alleviates Doxorubicin Resistance in Breast Cancer Through Inhibition of Epithelial-mesenchymal Transition By Targeting DUSP4." Cell Death Dis 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.